Synendos Therapeutics
Series ASynendos Therapeutics raised €19M in a Series A round in Nov 2020. The company is based in Allschwil, Switzerland. Investors in the round: Kurma Partners, Sunstone Life Science Ventures. Data as of Nov 2026.
Amount raised
€19M
€18,530,529
Native amount
20,000,000 CHF
Stage
Series A
series a
Investors
2
Provenance & confidence
High confidenceAmount
20,000,000 CHF
ECB-at-date → €19M · rate 1.0793 on 2020-11-11
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
Nov 2020
Round type
series a
Amount (EUR)
€19M
Other rounds
same companyThis is the company's only recorded round.